Xuesong Liang

发表

Regulatory B Cells Dysregulated T Cell Function in an IL-35-Dependent Way in Patients With Chronic Hepatitis B

G. Tang, Z. Tian, Ying Luo, 2021, Frontiers in Immunology.

Mental distress among frontline healthcare workers outside the central epidemic area during the novel coronavirus disease (COVID-19) outbreak in China:A cross-sectional study

YaYun Liu, Xuesong Liang, B. Gao, 2020 .

Disease Progression of Hospitalized Elderly Patients with Omicron BA.2 Treated with Molnupiravir

Xu Dong, Lingling Ge, Shiyong Fan, 2022, Infectious Diseases and Therapy.

Serum HBV RNA Dynamic and Drug Withdrawal Predictor Value in Patients With Chronic HBV Infection on Long-term Nucleos(t)ide Analogue (NA) Therapy

W. Liao, Hongli Yan, YaYun Liu, 2020, Journal of clinical gastroenterology.

Viral infection parameters not nucleoside analogue itself correlates with host immunity in nucleoside analogue therapy for chronic hepatitis B.

YaYun Liu, Xuesong Liang, Cheng-zhong Li, 2014, World journal of gastroenterology.

Serum HBV RNA quantification: useful for monitoring natural history of chronic hepatitis B infection

Hongli Yan, YaYun Liu, Meng Jiang, 2019, BMC Gastroenterology.

Long-term nucleoside analogue therapy can lead effective HBV DNA inhibition in patients with chronic HBV infection in immune tolerate phase

YaYun Liu, Xuesong Liang, Ai-ling Xu, 2020 .

Metagenomic next-generation sequencing (mNGS) confirmed a critical case of severe fever with thrombocytopenia syndrome virus (SFTSV)

Xuesong Liang, Jiao Yu, Tong Zhu, 2021, Clinical chemistry and laboratory medicine.

Gastrointestinal symptoms of long COVID-19 related to the ectopic colonization of specific bacteria that move between the upper and lower alimentary tract and alterations in serum metabolites

Xia Yang, Zhendong Jin, Ruhao Wu, 2023, BMC Medicine.

Hepatocellular carcinoma with worsened hypoglycemia after transarterial chemoembolization: a case report and systematic review.

Xuesong Liang, Chengzhong Li, W. Fan, 2020, International journal of clinical and experimental pathology.

Early Serum HBV RNA Level in Combination With the HBeAg Response Can Effectively Predict the HBeAg Response in Patients on Nucleos(t)ide Analogue Therapy (ClinicalTrials.gov (NCT03909191)

W. Liao, J. Yu, X. Liang, 2021 .